Read + Share
Amedeo Smart
Independent Medical Education
McKeigue PM, Porter D, Hollick RJ, Ralston SH, et al. Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland. Scand J Rheumatol 2023;52:412-417.PMID: 35549809
Email
LinkedIn
Facebook
Twitter
Privacy Policy